2025-04-02 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

**0. Key Figures Overview:**

Colgate-Palmolive (CL) is a multinational consumer goods company specializing in oral hygiene, personal care, and home care products.  The company shows a cumulative return significantly lagging behind the S&P 500 (VOO) over the analyzed period.  Recent price movements indicate a relatively stable, albeit slightly upward trending, stock price.  Profitability metrics display consistency, although ROE exhibits substantial volatility.

**1. Performance Comparison with S&P 500 (VOO):**

* **CL Cumulative Return:** 43.01%
* **VOO (S&P 500) Cumulative Return:** 89.44%
* **Return Difference:** -46.4%  (This indicates CL underperformed VOO significantly.)
* **Relative Lag:** 32.2% (This means CL's underperformance is at the 32.2nd percentile relative to its historical range of underperformance against VOO.)

The provided Alpha and Beta analysis shows mixed results. While some periods show positive alpha (outperformance), others indicate underperformance against the market (negative alpha). Beta values are generally above 1, suggesting higher volatility compared to the market.  Capitalization (Cap) shows a generally upward trend.


**2. Recent Price Movement:**

* **Closing Price:** $93.90
* **5-Day Moving Average:** $93.13
* **20-Day Moving Average:** $92.09
* **60-Day Moving Average:** $89.52

The stock price is currently trading above its 5, 20, and 60-day moving averages, suggesting a short-term upward trend.  The small increase from the previous close ($0.21) is not significant enough to warrant a characterization as "rapid increase" or "rapid decrease".


**3. Technical Indicators and Expected Return:**

* **Market Risk Indicator (MRI):** 0.4382 (Medium Risk)
* **RSI:** 63.75 (Neither overbought nor oversold; slightly above neutral.)
* **PPO:** 0.23 (Positive, suggesting upward momentum.)
* **20-Day Relative Divergence Change:** +11.9% (Short-term upward trend.)
* **Expected Return:** -78.5% (This negative expected return relative to the S&P 500 is noteworthy and needs further investigation to understand the underlying assumptions.)


**4. Recent Earnings Analysis:**

| Date       | EPS  | Revenue      |
|------------|------|---------------|
| 2024-10-25 | $0.9 | $5.03B        |
| 2024-07-26 | $0.89 | $5.06B        |
| 2024-04-26 | $0.83 | $5.07B        |
| 2023-10-27 | $0.86 | $4.92B        |
| 2024-10-25 | $0.86 | $4.92B        | *(Duplicate entry, likely an error)*


EPS shows a slight upward trend, while revenue remains relatively stable.  The duplicate entry needs clarification.

**5. Financial Information:**

**Revenue and Profitability:**

| Quarter | Revenue  | Profit Margin |
|---------|----------|---------------|
| 2024-12-31 | $4.95B  | 60.30%       |
| 2024-09-30 | $5.03B  | 61.08%       |
| 2024-06-30 | $5.06B  | 60.62%       |
| 2024-03-31 | $5.07B  | 60.00%       |
| 2023-12-31 | $4.95B  | 59.60%       |

Revenue is relatively stable, with profit margins consistently high, fluctuating slightly around 60%.

**Capital and Profitability:**

| Quarter | Equity   | ROE          |
|---------|----------|---------------|
| 2024-12-31 | $0.21B  | 348.58%      |
| 2024-09-30 | $0.43B  | 169.43%      |
| 2024-06-30 | $0.12B  | 594.31%      |
| 2024-03-31 | $0.23B  | 296.96%      |
| 2023-12-31 | $0.61B  | 117.90%      |

ROE shows extreme volatility, requiring further investigation to understand the underlying causes.  Equity figures also fluctuate significantly.


**6. Overall Analysis:**

Colgate-Palmolive (CL) shows consistent profitability with relatively stable revenue. However, the stock significantly underperformed the S&P 500 over the analyzed period, leading to a negative expected return in the provided data (-78.5%).  The high volatility in ROE and equity figures necessitates careful examination of the company's financial statements.  While short-term indicators suggest a slightly upward trend,  the significant underperformance relative to the market and the unusual volatility in ROE warrant further due diligence before making any investment decisions.  The -78.5% expected return requires careful consideration and a review of the methodology used for its calculation. The duplicate entry in the earnings data needs correction.
